Psoriasis Clinical Trials in Frankfurt Am Main, HESSE

About Psoriasis Clinical Trials in Frankfurt Am Main

Psoriasis is a chronic autoimmune skin condition affecting over 8 million Americans, causing cells to build up rapidly on the surface and forming red, scaly patches that can be itchy and painful. Plaque psoriasis accounts for about 80-90% of cases. While current treatments include topical therapies, phototherapy, and biologics like TNF inhibitors (adalimumab, etanercept) and IL-17/IL-23 inhibitors (secukinumab, guselkumab), clinical trials are testing next-generation oral treatments, TYK2 inhibitors, and combination approaches that may offer longer remission periods with fewer side effects. Patients with moderate-to-severe psoriasis who have not responded adequately to existing therapies are often sought for clinical trial enrollment.

There are currently 1 psoriasis clinical trials recruiting participants in Frankfurt Am Main, HESSE. These studies are seeking a combined 90 participants. Research is being sponsored by UCB Biopharma SRL. Clinical trial participation is free and participants receive study-related medical care at no cost.